S
Sandoz Group AG
SIX:SDZ
Sandoz Group AG
SIX:SDZ
Price:
61.2
CHF
-3.5%
Market Cap:
CHf26.9B
Relative Value
The Relative Value of one SDZ stock under the Base Case scenario is hidden CHF. Compared to the current market price of 61.2 CHF, Sandoz Group AG is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SDZ Relative Value
HIDDEN
Multiples Across Competitors
SDZ Competitors Multiples
Sandoz Group AG Competitors
Sandoz Group AG Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CH |
S
|
Sandoz Group AG
SIX:SDZ
|
26.5B CHF | 3 | 37.2 | 15.4 | 19.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
944.6B USD | 14.5 | 45.8 | 30.9 | 32.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.1B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
262.8B CHF | 4.3 | 20.4 | 12 | 13.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.9B CHF | 5.3 | 21.4 | 13.3 | 17 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
223.2B GBP | 5.1 | 29.5 | 16.3 | 23 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
287.6B USD | 4.4 | 15.8 | 9.8 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.9 | 8 | 9.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.2B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.7B USD | 2.5 | 17.1 | 7.2 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
